Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptionsMany patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.
Novo Nordisk Annual Sales Jump on Demand for Ozempic and WegovyNovo Nordisk reported strong earnings in 2024 but expects slower sales growth in 2025 due to competition.The company’s share price has fallen dramatically amid uncertainties in the obesity drug market.
Novo Nordisk's Wegovy sales jump on international rolloutsWegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptionsMany patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.
Novo Nordisk Annual Sales Jump on Demand for Ozempic and WegovyNovo Nordisk reported strong earnings in 2024 but expects slower sales growth in 2025 due to competition.The company’s share price has fallen dramatically amid uncertainties in the obesity drug market.
Novo Nordisk's Wegovy sales jump on international rolloutsWegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
A Drug Half as Good as Ozempic for One-30th the PriceNew obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.
Is Ozempic an Obesity Drug, or an Everything Drug?The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.
Obesity drugs: huge study highlights new health risksGLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
Weight-loss drug coverage is up in 2024 at the largest U.S. companies, a survey revealsMore U.S. employers are now covering weight-loss drugs, reflecting growing trends in healthcare benefits.
You Could Take Ozempic and Not Lose Any WeightObesity drugs like Wegovy and Zepbound are highly effective for some people but not for everyone.A significant number of patients do not respond to or cannot tolerate the side effects of these drugs.
Patients Hate Forever' Drugs. Is Wegovy Different?Nonadherence to prescribed medications is a common issue with significant consequences.Obesity drugs like Wegovy and Zepbound are showing promise in improving medication adherence.
A Drug Half as Good as Ozempic for One-30th the PriceNew obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.
Is Ozempic an Obesity Drug, or an Everything Drug?The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.
Obesity drugs: huge study highlights new health risksGLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
Weight-loss drug coverage is up in 2024 at the largest U.S. companies, a survey revealsMore U.S. employers are now covering weight-loss drugs, reflecting growing trends in healthcare benefits.
You Could Take Ozempic and Not Lose Any WeightObesity drugs like Wegovy and Zepbound are highly effective for some people but not for everyone.A significant number of patients do not respond to or cannot tolerate the side effects of these drugs.
Patients Hate Forever' Drugs. Is Wegovy Different?Nonadherence to prescribed medications is a common issue with significant consequences.Obesity drugs like Wegovy and Zepbound are showing promise in improving medication adherence.
Consultations for obesity drug prescriptions are way up over 2023, survey findsThe demand for consultations about obesity drugs is surging, particularly influenced by social factors and public figures.
Weight loss drugs could soon be covered by Medicare and MedicaidThe Biden administration aims to expand Medicare and Medicaid coverage to include obesity drugs, addressing outdated legislative exclusions.
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is overHims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.
You've Lost Weight Taking New Obesity Drugs. What Happens if You Stop?Patients who lose weight with obesity drugs face challenges and uncertainty on how to maintain their weight loss once they reach their goal.
from Fortune Europe6 months agoAn obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market valuePositive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.
How to Get Off OzempicObesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.
Patients Hate Forever' Drugs. Is Wegovy Different?Obesity drugs like Wegovy and Zepbound show potential in improving medication adherence.
How to Get Off OzempicObesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.
Patients Hate Forever' Drugs. Is Wegovy Different?Obesity drugs like Wegovy and Zepbound show potential in improving medication adherence.
The Ozempic Revolution Is StuckObesity drugs like Wegovy were originally created for different purposes, now being repurposed for heart health.FDA approval of Wegovy for heart health could open access to more Americans, but drug shortages remain a significant barrier.
Weight-loss drugs are forcing changes to grocery store offeringsFood companies are adapting products to cater to the changing appetites of consumers prescribed new obesity and diabetes drugs.
Doctors Test the Limits of What Obesity Drugs Can FixNew obesity drugs like Wegovy can positively impact other health conditions like arthritis and high blood pressure.